Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
FDA advisers resoundingly reject BrainStorm's ALS drug
FDA advisers agreed with staffers' concerns about BrainStorm's cell therapy for ALS, resoundingly voting against the treatment's potential efficacy.
Max Bayer
Sep 27, 2023 6:04pm
Revvity rolls out base editing reagents for preclinical labs
Sep 28, 2023 1:57pm
Sponsored
Improving the Drug Development Process with Organ-Chips
Sep 25, 2023 8:00am
Cancer report shows how diagnoses fell during the COVID pandemic
Sep 28, 2023 1:07pm
Sponsored
Uncover the Rare Disease Patient Journey
Sep 25, 2023 8:00am
Karuna’s new schizophrenia drug reaches FDA’s desk
Sep 28, 2023 11:12am
Medtech News
Harbinger nets $140M for blood-based cancer screening platform
Sep 28, 2023 10:49am
Yamaha revs up new antibody profiling business Tuning Fork Bio
Sep 28, 2023 10:35am
Merck KGaA grows Quris toxicity AI pact, continuing deal flurry
Sep 28, 2023 10:10am
Philips suppressed concerns years before CPAP recall: ProPublica
Sep 27, 2023 1:58pm
See More Medtech News
